Avanos Medical (AVNS) Appoints Camille Chang Gilmore as SVP and Chief Human Resources Officer

Avanos Medical, Inc. (NYSE:AVNS) is one of the best undervalued medical device stocks to buy now. On June 9, Avanos Medical, Inc. (NYSE:AVNS) announced the appointment of Camille Chang Gilmore as senior vice president, SVP, and chief human resources officer.

The transition would put her in charge of all aspects of the company’s people strategy, including workforce planning, talent acquisition and development, and leadership development and employee experience.

Avanos Medical, Inc. (NYSE:AVNS) announced $167.5 million in total net sales in fiscal Q1 2025, a 0.8% growth from the same period last year. Net income for the quarter reached $6.6 million, compared to net income from continuing operations of $0.5 million a year ago.

Adjusted net income also rose to $12.0 million, compared to $10.1 million in the same period last year.

Avanos Medical, Inc. (NYSE:AVNS) is a medical technology company that delivers medical device solutions and products to healthcare providers and patients.

While we acknowledge the potential of AVNS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.